Literature DB >> 31134449

Neuroendocrine carcinoma of the esophagus with an adenocarcinoma component.

Yuki Kaneko1, Shin Saito2, Kazuya Takahashi1, Rihito Kanamaru1, Yoshinori Hosoya1, Hironori Yamaguchi3, Joji Kitayama1, Toshiro Niki4, Alan Kawarai Lefor1, Naohiro Sata1.   

Abstract

A 68-year-old male was referred with dysphagia. Endoscopic findings showed circular stenosis with a protruding mass in the lower esophagus. Biopsy showed adenocarcinoma and there was no evidence of distant metastases. A subtotal esophagectomy was performed. The resected specimen revealed a mixed neuroendocrine carcinoma with adenocarcinoma. The adenocarcinoma component was on the surface of the tumor and the neuroendocrine component invaded the deeper portion. Immunohistochemically, the neuroendocrine carcinoma component stained positive for cytokeratin 7 and cytokeratin 20, suggesting that the neuroendocrine carcinoma originated from the adenocarcinoma. The adenocarcinoma component stained positive for MUC2, which suggests that the adenocarcinoma component originated from Barrett's epithelium. Taken together, the neuroendocrine carcinoma may have originated from Barrett's epithelium. A metastasis to the liver was found 2 months after the surgical resection. Chemotherapy was administered, but there was no response. Most esophageal neuroendocrine carcinomas are accompanied by adenocarcinoma or squamous cell components, suggesting that these carcinomas originate from pluripotent cells in squamous or Barrett's epithelium. Appropriate chemotherapy for these lesions should be considered based on the cell of origin.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal neuroendocrine carcinoma; Mixed adenoneuroendocrine carcinoma; Origin of neuroendocrine carcinomas

Mesh:

Substances:

Year:  2019        PMID: 31134449     DOI: 10.1007/s12328-019-00995-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  15 in total

1.  Barrett esophagus-associated small cell carcinoma.

Authors:  M C Saint Martin; G Chejfec
Journal:  Arch Pathol Lab Med       Date:  1999-11       Impact factor: 5.534

2.  MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.

Authors:  Maria G McIntire; Genevieve Soucy; Thomas L Vaughan; Aliakbar Shahsafaei; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2011-07       Impact factor: 6.394

3.  Combined oesophageal adenocarcinoma and carcinoid in Barrett's oesophagitis: potential role of enterochromaffin-like cells in oesophageal malignancy.

Authors:  N R Cary; D J Barron; J P McGoldrick; F C Wells
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

4.  Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases.

Authors:  Masako Asayama; Nozomu Fuse; Takayuki Yoshino; Tomonori Yano; Makoto Tahara; Toshihiko Doi; Satoshi Fujii; Atsushi Ohtsu
Journal:  Cancer Chemother Pharmacol       Date:  2011-04-03       Impact factor: 3.333

5.  Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.

Authors:  Dipen M Maru; Hema Khurana; Asif Rashid; Arlene M Correa; Sharmila Anandasabapathy; Sunil Krishnan; Ritsuko Komaki; Jaffer A Ajani; Stephen G Swisher; Wayne L Hofstetter
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

6.  Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection.

Authors:  Han-Yu Deng; Peng-Zhi Ni; Yun-Cang Wang; Wen-Ping Wang; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 7.  Primary neuroendocrine neoplasm of the esophagus - Report of 14 cases from a single institute and review of the literature.

Authors:  Francisco Tustumi; Flavio Roberto Takeda; Rodrigo Hideki Uema; Guilherme Luiz Stelko Pereira; Rubens Antonio Aissar Sallum; Ivan Cecconello
Journal:  Arq Gastroenterol       Date:  2017 Jan-Mar

8.  Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer.

Authors:  Xiaoguang Xiao; Shujing Wang; Shu Xia; Man Zou; Yang Li; Yao Wei; Qi Mei; Yuan Chen
Journal:  Onco Targets Ther       Date:  2015-08-21       Impact factor: 4.147

9.  Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus.

Authors:  Toshihiro Kitajima; Sachiko Kaida; Seigi Lee; Shusuke Haruta; Hisashi Shinohara; Masaki Ueno; Koichi Suyama; Yasunori Oota; Takeshi Fujii; Harushi Udagawa
Journal:  World J Surg Oncol       Date:  2013-09-04       Impact factor: 2.754

10.  Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases.

Authors:  Akinori Egashira; Masaru Morita; Reiko Kumagai; Ken-Ichi Taguchi; Masanobu Ueda; Shohei Yamaguchi; Manabu Yamamoto; Kazuhito Minami; Yasuharu Ikeda; Yasushi Toh
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

View more
  1 in total

1.  Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome.

Authors:  Zaryab Umar; Usman Ilyas; Ibironke Otusile; Ian Landry
Journal:  Cureus       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.